We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New RNAi Treatment Targets Eye Inflammation

News   Feb 15, 2017 | Original story from Hokkaido University

 
New RNAi Treatment Targets Eye Inflammation

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left). Credit: Hokkaido University

 
 
 

RELATED ARTICLES

World’s First Genetically Enhanced Human Vascular Cells

News

Scientists have generated the world's first genetically enhanced human vascular cells by targeting a single longevity gene, FOXO3.

READ MORE

Protein Interactions Shed Light on Ebola Virus Replication

News

Researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

READ MORE

Embryonic Chick Study Reveals How Cells are Recruited to Form Hindgut

News

New study uses live imaging to understand a critical step in early embryonic development—how genes and molecules control forces to orchestrate the emergence of form in the developing embryo.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE